[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356507-105":59,"doc-detail-356507-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","spatial-analysis-of-intraductal-papillary-mucinous-neoplasms-defines-a-paradoxical-keratin-17-positive-low-grade-epithelial-population-harboring-malignant-features","Spatial Analysis of Intraductal Papillary Mucinous Neoplasms Defines a Paradoxical Keratin 17-positive, Low-grade Epithelial Population Harboring Malignant Features","","Spatial transcriptomic analyses were used to map gene-expression profiles across the disease spectrum of intraductal papillary mucinous neoplasms (IPMNs). A histologically low-grade IPMN epithelial subpopulation was identified that carries higher-risk malignant transcriptional features, including KRT17. Immunostaining in patient tissues validated Keratin 17-positive cells, present as a small subset with patchy spatial distribution. This Keratin 17-marked transitional-like state may help explain cyst progression and supports development of clinically usable biomarkers for risk stratification.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/spatial-analysis-of-intraductal-papillary-mucinous-neoplasms-defines-a-paradoxical-keratin-17-positive-low-grade-epithelial-population-harboring-malignant-features/356507/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/spatial-analysis-of-intraductal-papillary-mucinous-neoplasms-defines-a-paradoxical-keratin-17-positive-low-grade-epithelial-population-harboring-malignant-features/356507.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What challenge does the study address in IPMN management?","Question",{"text":112,"@type":113},"Current guidelines lack sufficient accuracy to determine which IPMN patients need resection versus surveillance, contributing to overtreatment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers identify the higher-risk cell population?",{"text":117,"@type":113},"They applied spatial transcriptomics to patient samples spanning low-grade dysplasia, high-grade dysplasia, and IPMN-derived carcinoma, then used immunostaining to validate a Keratin 17-positive subset.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the significance of Keratin 17 in the findings?",{"text":121,"@type":113},"Keratin 17 marks a distinct transcriptional signature in a subpopulation of epithelial cells within histologically low-grade IPMN, consistent with a transitional state associated with progression to carcinoma.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356507,1790212186,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","ORIGINAL RESEARCH  \nSpatial Analysis of Intraductal Papillary Mucinous Neoplasms   Defines a Paradoxical Keratin 17-positive, Low-grade Epithelial Population Harboring Malignant Features  \nJay Li,1 Georgina Branch,2 Justin Macchia,2 Ahmed M. Elhossiny, 1 Nandini Arya,2  \nJulia Liang,2 Padma Kadiyala,2 Nicole Peterson,3 Richard Kwon,2 Jorge D. Machicado,2 Erik-Jan Wamsteker,2 Allison Schulman,2 George Philips,2 ,4 Stacy Menees,2 ,4 Jonathan Xia,2 Aatur D. Singhi,5 Vaibhav Sahai,3 ,6 ,7 Jiayun M. Fang,8 Timothy L. Frankel,6 ,7 ,9 , 10  \nFilip Bednar,6 ,7 , 10 Marina Pasca di Magliano,6 ,7 , 10 Jiaqi Shi,6 ,7 , 11 and Eileen S. Carpenter2 ,4 ,6 ,7  \n1Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan; 2Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; 3Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; 4Division of Gastroenterology, Veterans Affairs Health System, Ann Arbor, Michigan; 5Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania; 6Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan; 7Rogel and Blondy Center for Pancreatic Cancer, University of Michigan, Ann Arbor, Michigan; 8Department of Pathology, Veteran Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan; 9Department of Surgery, Veteran Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan; 10Department of Surgery, University of Michigan, Ann Arbor, Michigan; and 11Department of Pathology, University of Michigan, Ann Arbor, Michigan  \n\n| IPMN Disease Progression |  |\n| --- | --- |\n| \u003Cbr>Optional template C\u003Cbr>| |\n\nSUMMARY  \nWe utilized a spatial transcriptomic approach to analyze gene expression profiles across the spectrum of intraductal papillary mucinous neoplasm disease. We identified asubpopulation of histologically low-grade intraductal papillary mucinous neoplasms harboring higher-risk malignant features and validated this population with immunostaining in patient tissues.  \nWHAT YOU NEED TO KNOW  \nBackground: Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cystic lesions with malignant potential; however, determining which cysts will progress to pancreatic cancer remains challenging due to limited reliable biomarkers.  \nImpact: We have identified a subpopulation of histologically low-grade IPMN epithelial cells that express high-risk malignant features, including Keratin 17, potentially representing a transitional cell state associated with disease progression.  \nFuture Directions: Validation of this cell population may elucidate mechanisms underlying cyst progression and ultimately could translate into clinically applicable biomarkers to improve risk stratification and guide management of IPMNs.  \n2 Li et al Cellular and Molecular Gastroenterology and Hepatology Vol. 20, Iss. 6  \nBACKGROUND & AIMS: Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cysts that represent one of the few radiologically identifiable precursors to pancreatic ductaladenocarcinoma (PDAC). Although the IPMN-bearing patient population represents a unique opportunity for early detection and interception, current guidelines provide insufficient accuracy in determining which patients should undergo resection vs surveillance, resulting in a sizable fraction of resected IPMNs only harboring low-grade dysplasia, suggesting that there may be overtreatment of this clinical entity.  \nMETHODS: To investigate the transcriptional changes that occur during IPMN progression, we performed spatial transcriptomics using the Nanostring GeoMx on patient samples containing the entire spectrum of IPMN disease including low-grade dysplasia, high-grade dysplasia, and IPMN-derived carcinoma. Single-cell RNA sequencing was performed on side branch and main duct IPMN biospecimens.  \nRESULTS: We identified a subpopulation of histologically low-grade IPMN epithelial cells","cbCaibn9OT6M67vk","https://ap.wps.com/l/cbCaibn9OT6M67vk","pdf",21018500,18,"English","# Summary\n# What You Need to Know\n## Background\n## Impact\n## Future Directions\n# Background & Aims\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What challenge does the study address in IPMN management?\",\"answer\":\"Current guidelines lack sufficient accuracy to determine which IPMN patients need resection versus surveillance, contributing to overtreatment.\"},{\"question\":\"How did the researchers identify the higher-risk cell population?\",\"answer\":\"They applied spatial transcriptomics to patient samples spanning low-grade dysplasia, high-grade dysplasia, and IPMN-derived carcinoma, then used immunostaining to validate a Keratin 17-positive subset.\"},{\"question\":\"What is the significance of Keratin 17 in the findings?\",\"answer\":\"Keratin 17 marks a distinct transcriptional signature in a subpopulation of epithelial cells within histologically low-grade IPMN, consistent with a transitional state associated with progression to carcinoma.\"}]","Spatial Analysis of Intraductal Papillary Mucinous Neoplasms Defines a Paradoxical Keratin 17-positive, Low-grade Epithelial Population Harboring Malignant Features | PDF",1790125706,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39c3e4de6eda6ac7165c0ed4d4dbab45.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/063464b0f80304aa852add9a06b3f6a5.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/905440399e62965704fdbf4017932b49.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1731233161d35c5923550f88b0055c4e.webp",980,1292]